GUIDE Committee
E. David Crawford, M.D.
Co-Founder & GUIDE Chairman
Dr. Crawford is a a co-founder of The DDX Foundation. He has devoted his career in medicine to educating the public about men’s health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States.
He is currently a Professor of Urology at the University of California, San Diego, and emeritus distinguished endowed Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado. Dr. Crawford received his medical degree from the University of Cincinnati and his postgraduate training included an internship and residency in urology at the Good Samaritan Hospital in Cincinnati. He subsequently completed a genitourinary cancer fellowship at the University of California Medical Center in Los Angeles.
Karim Kader, MD, PhD
Co-Founder & GUIDE Chairman
Dr. Kader is a board-certified urologist who specializes in detecting, treating and preventing prostate cancer. He is nationally recognized for his expertise in performing robot-assisted radical cystectomy and urinary diversion for patients with bladder cancer. He holds several patents for genetic discoveries that show significant promise for early detection and prevention of prostate cancer. He is the principal investigator in numerous clinical research projects and has been published extensively.
Dr. Kader completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center in Houston and a residency in urology at the University of Toronto in Ontario, Canada. He earned his medical degree and doctoral degree from the University of British Columbia in Vancouver, British Columbia. Dr. Kader is board certified in urology.
Kirk J. Wojno, M.D.
Guide Committee Member
Dr. Wojno has over 30 years of experience in positions ranging from laboratory director, medical director, director of clinical research, and chief medical officer. He has served on scientific advisory boards and as a consultant to many of the top molecular diagnostic companies. He continues to educate the next generation of physicians and scientists and is a highly sought-after lecturer. He is also an active member of the College of American Pathologists as well as numerous other societies where he advocates for appropriate and ethical use of, as well as fair access to, advanced molecular laboratory testing. He truly strives to use his gifts to make a difference in patients lives.